Literature DB >> 31261230

Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients With Severe Illnesses.

En-Ting Wu1, Wuh-Liang Hwu1,2, Yin-Hsiu Chien1,2, Ching Hsu3, Ting-Fu Chen3, Nai-Qi Chen2, Hung-Chieh Chou1, Po-Nien Tsao1, Pi-Chuan Fan1, I-Jung Tsai1, Shuan-Pei Lin4, Wu-Shiun Hsieh1,5, Tung-Ming Chang6,7, Chi-Nien Chen8, Chen-Hao Lee9, Yen-Yin Chou10, Pao-Chin Chiu11, Wen-Hui Tsai12, Hann-Chang Hsiung13, Feipei Lai3, Ni-Chung Lee1,2.   

Abstract

OBJECTIVES: Critical illnesses caused by undiagnosed genetic conditions are challenging in PICUs. Whole-exome sequencing is a powerful diagnostic tool but usually costly and often fail to arrive at a final diagnosis in a short period. We assessed the feasibility of our whole-exome sequencing as a tool to improve the efficacy of rare diseases diagnosis for pediatric patients with severe illness.
DESIGN: Observational analysis.
METHOD: We employed a fast but standard whole-exome sequencing platform together with text mining-assisted variant prioritization in PICU setting over a 1-year period.
SETTING: A tertiary referral Children's Hospital in Taiwan. PATIENTS: Critically ill PICU patients suspected of having a genetic disease and newborns who were suspected of having a serious genetic disease after newborn screening were enrolled.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Around 50,000 to 100,000 variants were obtained for each of the 40 patients in 5 days after blood sampling. Eleven patients were immediately found be affected by previously reported mutations after searching mutation databases. Another seven patients had a diagnosis among the top five in a list ranked by text mining. As a whole, 21 patients (52.5%) obtained a diagnosis in 6.2 ± 1.1 working days (range, 4.3-9 d). Most of the diagnoses were first recognized in Taiwan. Specific medications were recommended for 10 patients (10/21, 47.6%), transplantation was advised for five, and hospice care was suggested for two patients. Overall, clinical management was altered in time for 81.0% of patients who had a molecular diagnosis.
CONCLUSIONS: The current whole-exome sequencing algorithm, balanced in cost and speed, uncovers genetic conditions in infants and children in PICU, which helps their managements in time and promotes better utilization of PICU resources.

Entities:  

Year:  2019        PMID: 31261230     DOI: 10.1097/PCC.0000000000002068

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  8 in total

1.  A retrospective cohort analysis of the Yale pediatric genomics discovery program.

Authors:  Samir Al-Ali; Lauren Jeffries; E Vincent S Faustino; Weizhen Ji; Emily Mis; Monica Konstantino; Cynthia Zerillo; Yong-Hui Jiang; Michele Spencer-Manzon; Allen Bale; Hui Zhang; Julie McGlynn; James M McGrath; Thierry Tremblay; Nina N Brodsky; Carrie L Lucas; Richard Pierce; Engin Deniz; Mustafa K Khokha; Saquib A Lakhani
Journal:  Am J Med Genet A       Date:  2022-07-28       Impact factor: 2.578

2.  The Impact of Rapid Exome Sequencing on Medical Management of Critically Ill Children.

Authors:  Amanda S Freed; Sarah V Clowes Candadai; Megan C Sikes; Jenny Thies; Heather M Byers; Jennifer N Dines; Mesaki Kenneth Ndugga-Kabuye; Mallory B Smith; Katie Fogus; Heather C Mefford; Christina Lam; Margaret P Adam; Angela Sun; John K McGuire; Robert DiGeronimo; Katrina M Dipple; Gail H Deutsch; Zeenia C Billimoria; James T Bennett
Journal:  J Pediatr       Date:  2020-06-15       Impact factor: 4.406

3.  Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China.

Authors:  Yingchao Liu; Chanjuan Hao; Kechun Li; Xuyun Hu; Hengmiao Gao; Jiansheng Zeng; Ruolan Guo; Jun Liu; Jun Guo; Zheng Li; Zhan Qi; Xinlei Jia; Wei Li; Suyun Qian
Journal:  Front Genet       Date:  2021-09-01       Impact factor: 4.599

4.  Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit.

Authors:  Erica Sanford Kobayashi; Bryce Waldman; Branden M Engorn; Katherine Perofsky; Erika Allred; Benjamin Briggs; Chelsea Gatcliffe; Nanda Ramchandar; Jeffrey J Gold; Ami Doshi; Elizabeth G Ingulli; Courtney D Thornburg; Wendy Benson; Lauge Farnaes; Shimul Chowdhury; Seema Rego; Charlotte Hobbs; Stephen F Kingsmore; David P Dimmock; Nicole G Coufal
Journal:  Front Pediatr       Date:  2022-01-24       Impact factor: 3.418

5.  Measures of Utility Among Studies of Genomic Medicine for Critically Ill Infants: A Systematic Review.

Authors:  Katharine Press Callahan; Rebecca Mueller; John Flibotte; Emily A Largent; Chris Feudtner
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Expanding the genotypes and phenotypes for 19 rare diseases by exome sequencing performed in pediatric intensive care unit.

Authors:  Juan Liu; Yu Zheng; Jiaotian Huang; Desheng Zhu; Ping Zang; Zhenqing Luo; Yongjia Yang; Yu Peng; Zhenghui Xiao; Yimin Zhu; Xiulan Lu
Journal:  Hum Mutat       Date:  2021-08-15       Impact factor: 4.700

7.  Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.

Authors:  Chieh-Wen Kuo; Wuh-Liang Hwu; Yin-Hsiu Chien; Ching Hsu; Miao-Zi Hung; I-Lin Lin; Feipei Lai; Ni-Chung Lee
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

8.  Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs.

Authors:  Claudia C Y Chung; Gordon K C Leung; Christopher C Y Mak; Jasmine L F Fung; Mianne Lee; Steven L C Pei; Mullin H C Yu; Vivian C C Hui; Joshua C K Chan; Jeffrey F T Chau; Marcus C Y Chan; Mandy H Y Tsang; Wilfred H S Wong; Joanna Y L Tung; Kin Shing Lun; Yiu Ki Ng; Cheuk Wing Fung; Mabel S C Wong; Rosanna M S Wong; Yu Lung Lau; Godfrey C F Chan; So Lun Lee; Kit San Yeung; Brian H Y Chung
Journal:  Lancet Reg Health West Pac       Date:  2020-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.